2009 Annual Meeting | Hallucinations in Parkinson's Disease: Pathogenesis and Practical Management

Date Monday 04/12/10

Time 07:30 PM - 10:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type After-Dinner Seminar

Director(s) Christopher Goetz, MD, FAAN

Topic(s) Cognitive Neurology/Neurologic Disorders Presenting with Psychiatric Symptoms

Learning Objectives Participants should be able to describe the gamut of hallucinations in Parkinson's disease; explain the multidimensional factors related to hallucinations; understand new research strategies and challenges; and discuss integrated treatment options.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
07:30 PM - 08:00 PM		Hallucinations: Clinical Spectrum and Diagnosis Jaime Kulisevsky, MD, PhD
07:30 PM - 10:30 PM		Reception
08:00 PM - 08:30 PM		Pathogenesis and Pathophysiology Christopher Goetz, MD, FAAN
08:30 PM - 09:00 PM		New Research Strategies Jennifer G. Goldman, MD, MS, FAAN
09:00 PM - 09:30 PM		Break
09:30 PM - 10:00 PM		Treatment Joseph H. Friedman, MD, FAAN
10:00 PM - 10:30 PM		Discussion

Faculty Disclosures
Joseph H. Friedman, MD, FAAN	No disclosure on file
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Jaime Kulisevsky, MD, PhD	Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia.
Jennifer G. Goldman, MD, MS, FAAN	Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.

��ɫ��

��ɫ��